Tag: zentalis pharmaceuticals
Zentalis: $2.5 billion deal to acquire Incyte Pharmaceuticals
Zentali, a German-Dutch biopharmaceutical company, is the latest company to sign a deal to buy Incytes, the leading manufacturer of drug-delivery systems in Europe.The agreement follows a $2 billion deal in 2015 by Incytix, a Dutch company that makes delivery systems for diabetes drugs.The acquisition will help bolster Zental’s growing portfolio of biopharma and injects […]
Continue Reading...
Lexicon pharmaceutical’s AZT drug is safe for use in Europe
LAS VEGAS — Lexicon Pharmaceuticals, the drug maker that makes Zentalis, said on Tuesday it will begin selling its Zentalisol drug in Europe, a move that comes as European regulators are investigating its safety.The company said it will sell the drug to pharmacies in the United Kingdom, France, Germany, Italy and Spain and expects to […]
Continue Reading...
Zynerba Pharmaceuticals stock rises by 4% in morning trading
ZYNERBA PLC shares climbed 4.9% in early trading after the pharmaceuticals firm said it had completed a trial of its anti-inflammatory drug.The company said on Thursday that it had started a Phase 2 study on the drug in patients with Crohn’s disease, ulcerative colitis and ulcerable colitis.It said the drug could be available by the […]
Continue Reading...
Which Pharma Companies Are Taking Over Our Health Care?
Zentalis Pharmaceuticals and Teva Pharmaceuticals, the leading maker of cancer drugs, are the latest to be taken over by pharmaceutical companies in the United States, a trend that could reshape the health care industry in the coming years.Teva’s acquisition of the Teva brand is the biggest of the big four, with Teva expected to close […]
Continue Reading...